“Aristotle Small/Mid Cap Equity Fund outperformed in Q1 2025 despite negative returns, benefiting from defensive positioning and strong security selection in healthcare and materials. The manager remains...”
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.